Replies to post #144732 on NanoViricides Inc. (NNVC)

[drkazmd65]

I agree with your interpretation here,... and it annoys the crap out of me.

Diwan is showing his usual ability to not focus on one thing at a time, and to chase those things that benefit himself and TheraCour, rather than those that might benefit the long-holding shareholders.

The anti-shingles topical would at least start to bring in some revenue IF they got it through clinical testing and it would also demonstrate the viability of the approach for the rest of any products that NNVC might bring into production next.